Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]
News [11454]
Articles [47]
Editorials [10]
Conferences [200]
elearning [4]
Tailoring treatment strategies in prostate cancer: expert insight
Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu
Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )
26 Sep 2015
Large variations found in survival from blood cancers between European countries
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
Large variations found in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...
Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA
CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )
26 Sep 2015
EUROCARE-5 results show large variations in survival from blood cancers between...
Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy
EUROCARE-5 results show large variations in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )
26 Sep 2015
Atrial fibrillation in CLL patients on ibrutinib
Prof Florence Cymbalista – University of Paris, Paris, France
Atrial fibrillation in CLL patients on ibrutinib ( Prof Florence Cymbalista – University of Paris, Paris, France )
10 Sep 2015
Circulating levels of tumour DNA in plasma may help monitor treatment response...
Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )
10 Sep 2015
Cytogenetic and proteomic prognostic markers of CLL
Dr Lauren Thurgood - Flinders University, Adelaide, South Australia
Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )
9 Sep 2015
Expert panel discussion: The best of iwCLL 2015
Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai
Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )
9 Sep 2015
Results of subgroup analysis of the HELIOS trial
Dr Paula Cramer – University of Cologne, Cologne, Germany
Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
8 Sep 2015
Primary results from the MABLE phase IIIb study
Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France
Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )
8 Sep 2015
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...
Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015
Results of a new phase Ib trial of voxtalisib in combination with...
Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation